Back

U-Prevent: a personalized approach to cardiovascular risk management

3 April 2025 (15:20 - 15:35)
Organised by: Logo
Congress Presentation Part of: From risk assessment to action: the role of icosapent ethyl in cardiovascular risk management Secondary Prevention Open Access ESC Preventive Cardiology 2025 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Doctor Jannick Dorresteijn

University Medical Center Utrecht, Utrecht (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Clinical Case Introduction
Professor V. Aboyans (Monaco, MC)
Slides Video
Presentation thumbnail
Understanding the clinical benefit of icosapent ethyl: insights from REDUCE-IT
Doctor H. Contractor (Manchester, GB)
Slides Video
Presentation thumbnail
Key takeaways: addressing residual cardiovascular risk with proven therapies
Professor G. De Ferrari (Turin, IT)
Slides Video
Presentation thumbnail
Q&A
Slides

Access the full session

Session thumbnail
From risk assessment to action: the role of icosapent ethyl in cardiovascular risk management
Video

The Event

Event poster

ESC Preventive Cardiology 2025

3 April 2025 15:20 CET
You may be interested in
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
thumbnail
Congress Presentation
Optimal medical therapy for primary prevention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources